Good morning :)
Place Order
Add to Watchlist

Chandra Bhagat Pharma Ltd

CBPL

Chandra Bhagat Pharma Ltd

CBPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,560
High RiskStock is 5.39x as volatile as Nifty
67.060.00% (+0.00)
67.060.00% (+0.00)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,560
High RiskStock is 5.39x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,560
High RiskStock is 5.39x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
—1.74—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Chandra Bhagat Pharma Ltd markets pharmaceutical critical care products, focusing on formulations for hospitals and healthcare centers, including injections and active pharmaceutical ingredients.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 16.87%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.05% to 0.06%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 16.62%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue80.2290.2897.73106.7294.4271.1895.70119.96232.70—
Raw Materialssubtract63.0779.1688.28103.6486.2653.7881.44104.57209.06—
Power & Fuel Costsubtract0.000.090.090.090.080.050.070.070.09
Employee Costsubtract7.265.645.024.532.251.851.521.322.18
Selling & Administrative Expensessubtract0.004.624.654.222.424.855.457.3017.75
Operating & Other expensessubtract6.08-4.10-5.57-10.80-0.156.482.763.08-0.66
Depreciation/Amortizationsubtract0.240.140.060.050.030.120.120.270.64—
Interest & Other Itemssubtract2.833.813.674.093.113.763.242.201.39—
Taxes & Other Itemssubtract0.370.250.500.200.110.090.300.250.74—
EPS8.8516.0324.6412.860.750.271.061.192.00—
DPS0.000.000.000.000.000.000.000.000.00—
Payout ratio0.000.000.000.000.000.000.000.000.00—
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Chandra Bhagat Pharma Ltd33.511.74—
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57—

Price Comparison

Compare CBPL with any stock or ETF
Compare CBPL with any stock or ETF
CBPL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.29%0.00%0.00%0.48%30.23%

Mar 2023

Sep 2023

Mar 2024

Sep 2024

Shareholding History

MarSepMarSepMarSep0.00%0.85%0.85%1.33%1.33%0.48%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

CBPL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Chandra Bhagat Pharma schedules board meeting

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Chandra Bhagat Pharma to conduct AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Chandra Bhagat Pharma schedules AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live